BIOMATION
Live / Registered — Registered (as of 24 Mar 2026)
What this means for you
Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98254291
- Registration number
- 8188410
- Mark type
- Stylized text
- Filed
- 03 Nov 2023
- Published for opposition
- 12 Mar 2024
- Registered
- 24 Mar 2026
- Attorney of record
- Mark E. Tetreault
Goods and services
- Class 007 — Machines and machine tools: Biomanufacturing devices for engineering of three-dimensional tissues, organs, and autologous cell samples, namely, 3D bioprinters; Fabrication devices for rejuvenation of tissues, organs, autologous cell samples, namely, tissue rejuvenation devices in the nature of bioprinters
- Class 009 — Scientific and electric apparatus: Automated and semi-automated cell culture apparatus for laboratory use, namely, automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers; Laboratory equipment and supplies, namely, incubators for cell culturing, cell therapy, tissue manufacturing and organ manufacturing and electronic monitors for monitoring cell culture incubators; Disposable plastic bioreactors for cell culturing; Biochips for the production of three-dimensional living tissues, organs and autologous cell samples for research or scientific purposes; Bioreactors for cell culturing for laboratory use; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers for the purpose of laboratory research; Automated and semi-automated medical equipment for the preparation of autologous and allogeneic biological cell therapies for medical purposes, namely, a fully integrated system composed primarily of computers, electronic sensors, and monitors, plastic tubing, syringes, and pumps, and metal containers, bottles, and heating plates for use in the creation of biological cell therapies, organs, tissues and autologous cell samples for medical purposes; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of medical and scientific research
- Class 010 — Medical apparatus: Automated and semi-automated cell culture apparatus for medical use, namely, automated fluid handling machines for cellular fluids, automated cell separation machines, and automated cell culture chambers; Medical devices, namely, electromechanical fluidic instruments, and other similar or related devices, which process complex human body fluids for the purpose of separating human cell culture samples, and separating fluids; Medical instruments for processing of human body fluids in the nature of human cell samples, blood, and plasma, and the isolation and concentration of components thereof for the purpose of treating degenerative diseases, and chronic diseases; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments in the nature of automated fluidic handling for the purpose of therapeutic regenerative medical treatment, blood transfusions, and cell transfusions
Owner
- DEKA Research & Development Corp., Manchester, NH, US
- DEKA Research & Development Corp., Manchester, NH, US
- DEKA Research & Development Corp., Manchester, NH, US
Prosecution history
- 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 03 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 03 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 03 Mar 2026 — SU-EXAMINER'S AMENDMENT WRITTEN
- 03 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Nov 2025 — NON-FINAL ACTION E-MAILED
- 03 Nov 2025 — SU - NON-FINAL ACTION - WRITTEN
- 29 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Sept 2025 — ASSIGNED TO LIE
- 18 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED